H.C. Wainwright cuts Dyne Therapeutics target price to $32 from $50
DYN•H.C. Wainwright cut its target price for Dyne Therapeutics to $32 from $50.
Related News
Apple plans to launch new smart-home hub on Oct. 13
AAPL•
Alto Ingredients Inc.: StoneX initiates coverage with buy rating; price target $7
ALTO•
Amazon: Rosenblatt Securities raises target price to $360 from $335
AMZN•
Goeasy renews securitization warehouse facility
GSY•
Erock Inc coverage initiated with buy rating and $24 price target
EROC•